Financial TimesNovartis upbeat despite end of Diovan patentFinancial TimesSales of Diovan, a treatment for high blood pressure, would fall by about $1.

Novartis AG's CEO Discusses Q4 2011 Results - Earnings Call TranscriptSeeking AlphaPharma had what I consider a very strong year with sales up 4% while absorbing 4 points of generic erosion on Femara in the US and on Diovan in parts of Europe.

NVS Beats By A Penny, View GuardedDaily MarketsFemara sales (down 62% to $134 million) were negatively impacted by generic erosion.

Exercise after breast cancer surgery can enhance recoveryTimes Herald-RecordKondagunta says that treatments prescribed to help prevent the recurrence of breast cancer — from radiation to drugs such as Tamaxifen or aromatose inhibitors such as Femara and Arimidex that manipulate hormonal status — can cause a host of side .

The Zacks Analyst Blog Highlights: J.